FDA approves CARDAMYST from MILESTONE PHARMS USA FDA Approval Dec. 31, 2025, 13:45 UTC Final approval of NDA #NDA #218571 for ETRIPAMIL. Decision date: 12/12/2025 Full text
There are no comments here yet...